General Callout
Nunc dolor esse suscipit eros eros ullamco dolor. Duis velaliquam sunt urna, tempuribud doming quis, laboris ultricies ultricies urna laboris. Nostrud pulvinar nostrud elit sunt ex exercitation magna tempuribud laboris ea ex nunc sed exercitation ea laboris dignissim.
Accordion
Quis harmud ea commodo voluptate dolor urna providerent tempor amet dignissim velit consectetur harmud sint doming, urna magna velit sed commodo urna sint sunt nunc. Nunc consectetur laboris harmud dolore exercitation sed magna laboris nulla velit velaliquam ultricies. Dignissim adipiscing, sed duis ultricies sint voluptate providerent nunc nisi.
Heading 1
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Heading 2
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Call to action
Esse suscipit in eros ea sed voluptate dolore, harmud nisi, dolore ultricies fugiat amet doming ut sint ut adipiscing. Sit velit velaliquam ex nunc ut voluptate
Blood glucose test strips (blood glucose test strips)
Status:
Concluded with an LOI
Manufacturer:
Tykess Pharmaceuticals Inc.
Indication:
Diabetes Mellitus, Type 1 & 2
Last updated August 12, 2021
Status:
Concluded with an LOI
Manufacturer:
Merck Canada Inc.
Indication:
Unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (CRC), for first-line treatment of adult patients
Last updated August 11, 2021
Status:
Concluded with an LOI
Manufacturer:
GlaxoSmithKline Inc.
Indication:
Ovarian Cancer: Maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy
Last updated August 11, 2021
Status:
Concluded with an LOI
Manufacturer:
GlaxoSmithKline Inc.
Indication:
Ovarian Cancer, monotherapy for the maintenance treatment of female adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
Last updated August 11, 2021
Status:
Concluded with an LOI
Manufacturer:
Astellas Pharma Inc.
Indication:
Metastatic Castration-Sensitive Prostate Cancer
Last updated July 30, 2021
Status:
Negotiations were not pursued
Manufacturer:
Celgene Inc.
Indication:
Multiple Sclerosis, Relapsing-Remitting
Last updated July 29, 2021
Status:
Concluded without agreement
Manufacturer:
Janssen Inc.
Indication:
Ulcerative Colitis
Last updated July 28, 2021
Suboxone (film) (buprenorphine and naloxone)
Status:
Concluded with an LOI
Manufacturer:
Indivior UK Limited
Indication:
Opioid Dependence
Last updated July 15, 2021
Status:
Concluded with an LOI
Manufacturer:
Hoffmann-La Roche Ltd.
Indication:
ROS1-positive Non-Small Cell Lung Cancer
Last updated July 6, 2021
Status:
Concluded with an LOI
Manufacturer:
Elvium Life Sciences
Indication:
Attention-deficit/hyperactivity disorder (ADHD)
Last updated June 29, 2021